electroCore, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
electroCore, Inc. (ECOR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-19
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-03-31 was 3.90%, a 143.75% increase year-over-year.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 1.60%, a 166.67% increase year-over-year.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.60%, a 57.14% decline year-over-year.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-06-30 was 0.50%.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.00%, a 2.44% decline from fiscal 2023.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.10%, a 95.24% increase from fiscal 2022.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.10%, a 200.00% increase from fiscal 2021.
- electroCore, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.70%, a 0.00% change from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2024-12-31 | 4.00% 10-K · filed 2026-03-19 | |||
| 2024-09-30 | 4.00% 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | 4.10% 10-K · filed 2025-03-12 | |||
| 2023-09-30 | 4.10% 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | 3.90% 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | 3.90% 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 2.10% 10-K · filed 2024-03-13 | |||
| 2022-09-30 | 1.70% 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | 1.70% 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 1.60% 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | 0.70% 10-K · filed 2023-03-08 | |||
| 2021-09-30 | 0.70% 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 0.70% 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 0.60% 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 0.70% 10-K · filed 2022-03-10 | |||
| 2020-09-30 | 0.70% 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 0.50% 10-Q · filed 2020-08-13 | 0.70% 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 1.40% 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 2.10% 10-K · filed 2021-03-11 | |||
| 2019-09-30 | 2.30% 10-Q · filed 2020-11-12 | |||
| 2019-03-31 | 2.40% 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | 2.70% 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |